Amid daily updates from the pharmaceuticals industry on the latest clinical trials, last week’s announcement by Hutchison China MediTech that it had enrolled patients for a study of colorectal cancer was hardly cause for excitement.
在制药业每天都宣布最新临床试验的大背景下，和黄manbetx3.0 医药科技(Hutchison China MediTech)上周宣布已征募病患参加结直肠癌研究的消息，算不上令人振奋。
您已阅读4%（316字），剩余96%（7184字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。